Viewing Study NCT02101593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-03-02 @ 10:04 PM
Study NCT ID: NCT02101593
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2014-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
Sponsor: Polaris Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None argininosuccinate synthetase View
None arginine View
None arginine deiminase View